Related Experiment Video
Updated: May 24, 2025

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
Published on: October 14, 2021
Multiple Primary Cutaneous Anaplastic Large Cell Lymphoma: A Case Report.
Aljoharah Al Saud1, Reem Alsergani2, Ahmed Alhumidi3
1College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
Cutaneous anaplastic large cell lymphoma (cALCL), a rare skin condition, is often misdiagnosed. This case highlights the importance of considering cALCL in persistent skin lesions, even with co-occurring infections.
Area of Science:
- Dermatology
- Oncology
- Pathology
Background:
- Anaplastic large cell lymphomas (ALCL) are a non-Hodgkin lymphoma subtype, with cutaneous (cALCL) and systemic forms.
- cALCL typically lacks ALK receptor expression and presents as skin lesions, often misdiagnosed due to rarity.
Purpose of the Study:
- To report a case of ALK-negative cALCL presenting as persistent skin lesions.
- To emphasize the diagnostic challenge of cALCL and its differentiation from other dermatological conditions.
Main Methods:
- A case presentation of a female patient with a 30-year history of evolving skin lesions.
- Diagnostic procedures included lesion biopsy, which revealed ALK-negative cALCL and methicillin-resistant Staphylococcus aureus.
- Systemic evaluation excluded secondary cALCL.
Main Results:
- Biopsy confirmed primary ALK-negative cutaneous anaplastic large cell lymphoma (cALCL).
- The patient also had a concurrent methicillin-resistant Staphylococcus aureus infection.
- Systemic ALCL was ruled out through comprehensive workup.
Conclusions:
- Persistent skin lesions warrant consideration of cALCL in the differential diagnosis.
- Early and accurate diagnosis of cALCL is crucial for appropriate management.
- This case underscores the diagnostic complexities associated with rare cutaneous lymphomas.
More Related Videos
10:52Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
Published on: March 30, 2018
09:29Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood
Published on: February 1, 2013